Is Cybin Inc (OTCMKTS:CLXPF) Stock a Good Buy After The Recent Rally?

August 5, 2021

Biotechnological company focusing on psychedelic therapeutics, Cybin Inc (OTCMKTS:CLXPF) on August 3, 2021, announced receiving conditional listing approval from the NYSE American stock exchange. CEO Doug Drysdale said that conditional approval is a vital milestone in the company’s journey. Drysdale said he expects expanded access for investors result in fueling the mission of developing revolutionary psychedelic therapeutics for patients having mental health conditions. However, the listing is subjected to approval…